Evidence map›Paper›PMID 32855511›Full record

ReviewPediatric research2020

New directions in necrotizing enterocolitis with early-stage investigators.

Troy A Markel, Colin A Martin, Hala Chaaban, Jennifer Canvasser, Heather Tanner, Heather Denchik, Misty Good

Abstract readReview
In one paragraph

Review in Pediatric research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Necrotizing Enterocolitis: What's New and What's Next?International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Troy A MarkelDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Colin A MartinThe Necrotizing Enterocolitis (NEC) Society, Davis, CA, USA.
Hala ChaabanThe Necrotizing Enterocolitis (NEC) Society, Davis, CA, USA.
Jennifer CanvasserThe Necrotizing Enterocolitis (NEC) Society, Davis, CA, USA.
Heather TannerThe Necrotizing Enterocolitis (NEC) Society, Davis, CA, USA.
Heather DenchikThe Necrotizing Enterocolitis (NEC) Society, Davis, CA, USA.
Misty GoodThe Necrotizing Enterocolitis (NEC) Society, Davis, CA, USA. mistygood@wustl.edu.

Funding

Modulation of the Intestinal Immune Response in Necrotizing EnterocolitisR01DK118568 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2018 to 2022
$1.8M
Mesenchymal Stromal Cells Modulate Intestinal Mesenteric Endothelium Via Hydrogen SulfideK08DK113226 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI MARKEL, TROY A · 2018 to 2021
$603k
Novel Anti-Inflammatory Properties of Breast Milk in Necrotizing EnterocolitisK08DK101608 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2014 to 2017
$584k
The Role of Extracellular Histones and Neutrophil Extracellular traps in Necrotizing EnterocolitisK08GM127308 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CHAABAN, HALA · 2017 to 2019
$275k
Aryl hydrocarbon receptor signaling in the pathogenesis of necrotizing enterocolitisR03DK111473 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2017 to 2018
$153k
NIDDK NIH HHS K08 DK101608NIDDK NIH HHS K08 DK113226NIDDK NIH HHS R01 DK118568NIDDK NIH HHS R03 DK111473NIGMS NIH HHS K08 GM127308
6 · The paper itself

Abstract

The 2019 Necrotizing Enterocolitis (NEC) Symposium expanded upon the NEC Society's goals of bringing stakeholders together to discuss cutting-edge science, potential therapeutics and preventative measures, as well as the patient-family perspectives of NEC. The Symposium facilitated discussions and shared knowledge with the overarching goal of creating "A World Without NEC." To accomplish this goal, new research to advance the state of the science is necessary. Over the last decade, several established investigators have significantly improved our understanding of the pathophysiology of NEC and they have paved the way for the next generation of clinician-scientists funded to perform NEC research. This article will serve to highlight the contributions of these young clinician-scientists that seek to elucidate how immune, microbial and nervous system dysregulation contributes to the pathophysiology of NEC.

Indexed as

AnemiaBlood TransfusionCell TransplantationCongresses as TopicEnteric Nervous SystemEnterocolitis, NecrotizingFamily HealthGastrointestinal MicrobiomeHumansInfantInfant, NewbornInfant, Newborn, DiseasesInfant, PrematureMesenchymal Stem CellsNeonatologyParents

Identifiers

PMID32855511
PMCPMC7934965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.